Kairos Pharma, Ltd. (KAPA) is a publicly traded Healthcare sector company. As of November 3, 2026, KAPA trades at $0.50 with a market cap of $1.79M and a P/E ratio of -3.19. KAPA moved +2.47% today. Year to date, KAPA is -90.56%; over the trailing twelve months it is -93.91%. Its 52-week range spans $0.48 to $14.77. Rallies surfaces KAPA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Kairos Pharma, Ltd. (KAPA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. KAPA moved +2.47% today.
| Metric | Value |
|---|---|
| Price | $0.50 |
| Market Cap | $1.79M |
| P/E Ratio | -3.19 |
| EPS | $-0.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $14.77 |
| 52-Week Low | $0.48 |
| Volume | 172.98K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-5.45M |
| Gross Margin | 0.00% |
KAPA analyst coverage data. Average price target: $0.00.